GFH 375
Alternative Names: GFH-375; GFH375/VS-7375; VS-7375Latest Information Update: 05 Jul 2024
At a glance
- Originator GenFleet Therapeutics
- Developer GenFleet Therapeutics; Verastem Oncology
- Class Antineoplastics; Small molecules
- Mechanism of Action KRAS protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I/II Solid tumours